New York State Teachers Retirement System (NYSTRS)’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Other funds holding SRPT
EAM
New York State Teachers Retirement System (NYSTRS)'s SRPT Position: Q2 2026 in Review
New York State Teachers Retirement System (NYSTRS) increased its Sarepta Therapeutics (SRPT) stake by 3.5% in Q2 2026, buying an estimated $64.6K and bringing the position to 100,515 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1131.
New York State Teachers Retirement System (NYSTRS) first reported a position in SRPT in Q2 2024 and has held it in 9 quarters since. The position peaked at $12.1M in Q2 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.
- New York State Teachers Retirement System (NYSTRS) held 100,515 shares of Sarepta Therapeutics worth $1.81M as of Q2 2026.
- New York State Teachers Retirement System (NYSTRS) bought 3,417 Sarepta Therapeutics shares in Q2 2026, an estimated $64.6K.
- Sarepta Therapeutics made up ﹤0.01% of New York State Teachers Retirement System (NYSTRS)'s portfolio in Q2 2026, its #1131 holding.
- New York State Teachers Retirement System (NYSTRS) first reported a position in Sarepta Therapeutics in Q2 2024 and has held it in 9 quarters since.
- New York State Teachers Retirement System (NYSTRS)'s Sarepta Therapeutics position peaked at $12.1M in Q2 2024.
- 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.
Based on New York State Teachers Retirement System (NYSTRS)'s 13F filing for Q2 2026, filed 23 Jul 2026.